AstraZeneca and Merck Sponsored Symposium

May 3, 2023
12:45 to 13:45 ET
Centre Mont-Royal

A Case for Universal Germline Genetic Testing for Newly Diagnosed Breast Cancer and the Impact on Patient Decisions


Kelly Metcalfe

Kelly Metcalfe, RN, PhD, FCAHS, FAAN

Senior Scientist, Women’s College Research Institute; Professor and Associate Dean of Research, Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada



Larissa Peck

Larissa Peck MSc, CGC

Genetic Counsellor, Princess Margaret Cancer Centre, Toronto, ON, Canada